Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2022-04-13 Report Publication Anno…
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) meeting (기업설명회). It provides details such as the date, time, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves or a financial report, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2022-04-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including the addition of special related parties and the granting of stock options. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in ownership levels and related party holdings.
2022-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting held on 2022-03-25, including financial statement approval, director appointments, and remuneration limits. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2022-03-25 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It explicitly lists the 'before' and 'after' names, the reason for the change (management efficiency), and the date of the board resolution. This falls directly under the category of board/management changes.
2022-03-25 Korean
주식매수선택권부여에관한신고
Remuneration Information Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It details the issuance of stock options to executives, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and executive compensation via stock options is classified as a regulatory filing (RNS) in the absence of a more specific category like 'Director's Dealing' (which usually refers to personal trades) or 'Remuneration' (which usually refers to annual compensation reports).
2022-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is titled '감사보고서 제출' (Submission of Audit Report) and provides a summary of the audit opinion, key financial figures, and the auditor's name. While it contains financial data, it is a formal regulatory filing announcing the submission of the audit report to the exchange, rather than the full annual report itself. Given the specific nature of the content (audit opinion and financial summary), it fits the 'Audit Report / Information' category. FY 2021
2022-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.